|
|
|
|
LEADER |
00000cam a2200000Ia 4500 |
001 |
SCIDIR_ocn277086607 |
003 |
OCoLC |
005 |
20231117015138.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
081206s1991 cau ob 001 0 eng d |
040 |
|
|
|a N$T
|b eng
|e pn
|c N$T
|d OCLCQ
|d UBY
|d IDEBK
|d E7B
|d OCLCQ
|d OPELS
|d OCLCQ
|d OCLCF
|d YDXCP
|d EBLCP
|d OCLCQ
|d MERUC
|d LEAUB
|d OCLCQ
|d OCLCO
|d INARC
|d OCLCO
|d COM
|d OCLCO
|d OCL
|d OCLCQ
|
019 |
|
|
|a 505149372
|a 646756432
|a 808731289
|a 907031474
|
020 |
|
|
|a 9780080578255
|q (electronic bk.)
|
020 |
|
|
|a 008057825X
|q (electronic bk.)
|
020 |
|
|
|a 0120224496
|q (electronic bk.)
|
020 |
|
|
|a 9780120224494
|q (electronic bk.)
|
035 |
|
|
|a (OCoLC)277086607
|z (OCoLC)505149372
|z (OCoLC)646756432
|z (OCoLC)808731289
|z (OCoLC)907031474
|
050 |
|
4 |
|a QR181
|b .A38eb vol. 49
|
072 |
|
7 |
|a MED
|x 044000
|2 bisacsh
|
082 |
0 |
4 |
|a 616.07/9
|2 22
|
096 |
|
|
|a QW 573
|f ADV
|
245 |
0 |
0 |
|a Advances in immunology.
|n Volume 49 /
|c edited by Frank J. Dixon.
|
260 |
|
|
|a San Diego :
|b Academic Press,
|c �1991.
|
300 |
|
|
|a 1 online resource (vii, 439 pages).
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Advances in Immunology ;
|v v. 49
|
504 |
|
|
|a Includes bibliographical references and index.
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a Front Cover; Advances in Immunology, Volume 49; Copyright Page; Contents; Chapter 1. Human Immunoglobulin Heavy-Chain Variable Region Genes: Organization, Polymorphism, and Expression; I. Introduction; II. Gross Organization of the Human Ig Complex; III. VH Families; IV. Polymorphism of VH Gene Segments; V.D Segments; VI. Human JH Segments; VII. Expression of Human VH Gene Segments; VIII. Regulation; IX. Conclusions; References; Chapter 2. Surface Antigens of Human Leucocytes; I. Introduction; II. Antigen-Specific Receptors; III. MHC Glycoproteins; IV. Adhesion Molecules.
|
505 |
8 |
|
|a V. Receptors for Immunoglobulins (Fc-Receptors)VI. Receptors for Complement Components; VII. Receptors for Lymphokines and Other Growth and Differentiation Factors; VIII. Membrane Enzymes; IX. Transport Proteins; X. Other Interesting Molecules; XI. Concluding Remarks; References; Note Added in Proof; Chapter 3. Expression, Structure, and Function of the CD23 Antigen; I. Introduction; II. Cellular Expression; III. Biochemical Structure; IV. Regulation of CD23 Cleavage; V. Regulation of CD23 Expression; VI. Molecular Biology of FceRII; VII. Biological Activity of CD23.
|
505 |
8 |
|
|a VIII. CD23 Expression in Various Clinical ConditionsIX. Conclusions; References; Chapter 4. Immunology and Clinical Importance of Antiphospholipid Antibodies; I. Introduction; II. Phospholipid Biochemistry; III. Historical Background; IV. Clinical Aspects of Antiphospholipid Antibodies; V. The Immunology of Antiphospholipid Antibodies; VI. The Pathogenic Potential of aPL Antibodies; VII. Summary and Conclusions; References; Chapter 5. Adoptive T Cell Therapy of Tumors: Mechanisms Operative in the Recognition and Elimination of Tumor Cells; I. Introduction.
|
505 |
8 |
|
|a II. Principles of Adoptive Therapy with Specifically Immune T CellsIII. Mechanisms by Which T Cells Mediate Tumor Rejection; IV. Recognition of Distinct Tumor Antigens by CD4+ and CD8+ T Cells as a Potential Basis for Selective Efficacy of a T Cell Subset; V. Accessory Cell, Antigen-Presenting Cell, and Cytokine Requirements for Effective Expression of Antitumor Responses by CD4+ and by CD8+ T Cell Subsets; VI. Concluding Statements; References; Chapter 6. The Development of Rational Strategies for Selective Immunotherapy against Autoimmune Demyelinating Disease; I. Introduction.
|
505 |
8 |
|
|a II. Multiple Epitopes of Myelin Basic Protein in Mice and HumansIII. Human and Rodent TCR Usage Restriction in T Cells Responding to Specific Epitopes of Myelin Basic Protein; IV. Possibilities for Future Immune Intervention in Multiple Sclerosis; References; Chapter 7. The Biology of Bone Marrow Transplantation for Severe Combined Immune Deficiency; I. Introduction; II. Severe Combined Immune Deficiency; III. Characteristics of Stem Cell Engraftment for the Correction of SCID; IV. Histocompatible Bone Marrow Transplantation; V. Transplantation with Fetal Tissues.
|
520 |
|
|
|a ADVANCES IN IMMUNOLOGY VOLUME 49.
|
650 |
|
0 |
|a Immunology.
|
650 |
|
2 |
|a Allergy and Immunology
|0 (DNLM)D000486
|
650 |
|
4 |
|a Allergy and immunology
|v Periodicals.
|
650 |
|
4 |
|a Allergy and immunology.
|
650 |
|
4 |
|a Immunology
|v Periodicals.
|
650 |
|
4 |
|a Immunology.
|
650 |
|
6 |
|a Immunologie.
|0 (CaQQLa)201-0066630
|
650 |
|
7 |
|a MEDICAL
|x Immunology.
|2 bisacsh
|
650 |
|
7 |
|a Immunology.
|2 fast
|0 (OCoLC)fst00968006
|
650 |
|
7 |
|a Immunologie.
|2 fmesh
|
650 |
|
7 |
|a Antig�enes.
|2 fmesh
|
650 |
|
7 |
|a Immunoth�erapie.
|2 fmesh
|
650 |
|
7 |
|a Transplantation moelle osseuse
|x biologie.
|2 fmesh
|
655 |
|
2 |
|a Periodical
|0 (DNLM)D020492
|
655 |
|
7 |
|a periodicals.
|2 aat
|0 (CStmoGRI)aatgf300026657
|
655 |
|
7 |
|a Periodicals.
|2 fast
|0 (OCoLC)fst01411641
|
655 |
|
7 |
|a Periodicals.
|2 lcgft
|
655 |
|
7 |
|a P�eriodiques.
|2 rvmgf
|0 (CaQQLa)RVMGF-000001105
|
700 |
1 |
|
|a Dixon, Frank J.
|q (Frank James),
|d 1920-2008.
|
776 |
0 |
8 |
|i Print version:
|t Advances in immunology. Volume 49.
|d San Diego : Academic Press, �1991
|z 0120224496
|z 9780120224494
|w (OCoLC)24893425
|
830 |
|
0 |
|a Advances in immunology.
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780120224494
|z Texto completo
|